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adjunctive or alternative target if these
new data are confirmed. Of course, pre-
vention of steatosis by proper nutrition
and exercise remains our primary goal.
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P R E V I E W SAn ARC light on lipid metabolism
The SREBP pathway plays a central role in the regulation of lipid metabolism. In a recent letter, Yang et al. present a com-
prehensive series of experiments, spanning a wide range of disciplines, that identify ARC105 as a component of the ARC
complex that interacts directly with SREBP and is necessary for SREBP function (Yang et al., 2006).As part of the effort to understand the
mechanistic basis for the cellular control
of lipid metabolism, much work has been
focused on dissecting the sterol regula-
tory element binding protein (SREBP)
pathway. In a recent paper, Yang et al.
(2006), demonstrate that a subunit of
the ARC complex, ARC105, interacts di-
rectly with SREBPs to enable transcrip-
tion from target promoters (Figure 1).
SREBPs are membrane bound tran-
scription factors that play a central role
in regulating lipid production in all meta-
zoans studied. This work has revealed
the intricate machinery responsible for
regulating the release of SREBPs from
the membrane in response to cellular
need for lipids. This machinery includes
two proteases, an escort factor and
retention factors, and is localized to intra-
cellular membranes (Brown and Gold-
stein, 1999; McPherson and Gauthier,
2004). Each of these components is nec-
essary to ensure regulated release of
SREBPs from the membrane and, thus,
access to the nucleus. Nuclear access
is not the end of the story, however.
Other work has focused on additional
proteins needed to form the final
transcriptionally active complex, once
SREBPs reach the nucleus. These cofac-
tors include CBP (the cAMP response
element binding protein [CREB] bindingCELL METABOLISM : SEPTEMBER 2006protein), a related protein, p300 (Oliner
et al., 1996), Sp1, Sp3, (Athanikar et al.,
1997), NFY (Ericsson et al., 1996), and
the large, multicomponent activator-
recruited cofactor (ARC) complex (or
the metazoan Mediator complex) (Naar
et al., 1999).
Delineating events at SREBP target
promoters more fully, Yang et al. (2006)
focused on a single subunit of the large
ARC complex. They report that interac-
tion between ARC105 and SREBPs is se-
lective; they detected no interaction be-
tween ARC105 and other transcription
factors, such as the cellular myeloblast
transforming factor (c-Myb) or CREB.
Similarly, SREBPs did not bind to other
ARC subunits tested. Thus interaction
between ARC105 and SREBP is not sim-
ply a general phenomenon of the tran-
scriptional machinery.
This selectivity is perhaps surprising.
ARC105 was first identified as an essen-
tial component of the complex required
for TGFb signaling via Smad2/3-Smad4
binding (Kato et al., 2002). In the present
study, the authors show that the SREBP-
interacting domain of ARC105 (a domain
that does not bind c-Myb or CREB) is
structurally similar to the KIX domain of
CBP (a domain that does bind c-Myb
and CREB). Changing just two residues
in the third a helix of ARC105 to the cor-responding residues in CBP (Ile64/Tyr;
Asp68/Lys) substantially improved the
ability of ARC105 to interact with both
c-Myb and CREB.
Interaction between ARC105 and
SREBPs is functionally significant; when
the authors used an siRNA strategy to re-
duce the abundance of ARC105 tran-
script in cultured cells, the transcription
of SREBP-responsive genes was greatly
reduced while transcription of several
other, non-SREBP-dependent genes re-
mained unaffected. This indicated that
the ARC complex could still function
with other transcription factors even
when levels of ARC105 were artificially
low. This is consistent with the selectivity
observed in the binding studies. Yang
et al. (2006) then used chromatin immu-
noprecipitation assays to demonstrate
joint occupancy of target promoters by
SREBP and ARC105.
Experiments conducted in the nema-
tode,C. elegans, whose genome harbors
orthologs of both SREBP (SBP-1) and
ARC105 (MDT-15), confirmed thephysio-
logical relevance of the interaction be-
tween ARC105 and SREBP. Disruption
of the expression of either gene by RNAi
resulted in highly similar phenotypes, in-
cluding growth defects, infertility, short-
ened lifespan, and reduced fat storage.
A clue to the direct cause of the defects181
P R E V I E W SFigure 1. Schematic representation of the interactions between components of the transcription machinery
Interaction between the ARC/Mediator complex (aqua) and SREBPs (yellow) occurs through binding of the KIX
domain of ARC105 to an amino-terminal region of SREBP (indicated in red). SREBPs bind to sterol regulatory
elements in the upstream region of target genes (SRE). The ARC complex also interacts (curved arrow) with
the COO--terminal domain of RNA polymerase II (Pol II; pink). General transcription factors (GTFs; blue) and
TFIID (green) are also indicated. Selective interaction between ARC105 and SREBPs occurs in nematodes
and in human cells but its regulatory significance is unclear at present. This essential interaction could confer
an additional level of control on the transcriptional regulation of lipid metabolism. The species indicated by
a question mark (?) highlights the possibility that other, perhaps unknown, protein(s) may serve functions anal-
ogous to ARC105 in mediating interactions between the ARC complex and SREBPs in circumstances different
from those described by Yang et al. (2006). Preventing interaction between ARC105 and SREBPs should dis-
rupt lipid metabolism, including the synthesis of fatty acids and, in mammals, cholesterol. (Adapted from Yang
et al. [2006]).in RNAi-treated animals came from anal-
ysis of their fatty acids. The ratio of stea-
rate (18:0) to oleate (18:1) increased in
RNAi-treatedwormscompared tovector-
treated worms, suggesting a deficit in
fatty acid desaturation. The abundance
of transcripts encoding stearoyl CoA de-
saturases (fat-6 and -7) was diminished
in animals treated with RNAi against
SBP-1orMDT-15.When these transcripts
were themselves targeted by RNAi, phe-
notypes similar to the SBP-1 and MDT-
15 knockdowns were observed.
The authors then tested the ability of
dietary supplementation with fatty acids
to ameliorate the phenotypes observed
in RNAi-treated worms. In contrast to
stearate, supplementation with oleate af-
forded substantial rescue. However, ole-
ate feeding reversed the growth defect in
MDT-15 and SBP-1 knockdown worms
less strongly than it reversed the growth
defect in the fat-6 and -7 knockdown an-
imals. Therefore, most, but not all, of the
defects associated with disruption of
SBP-1 transcription result from dimin-
ished desaturase activity and the conse-
quent deficit in the supply of oleate. This
differs from the case in Drosophila where
the desaturase genes do not appear to
be targets of dSREBP and lethality of
dSREBP null mutants can be substan-182tially rescued by stearate or oleate (as
well as other fatty acids; Kunte et al.,
2006). Nevertheless, feeding worms ole-
ate effectively ameliorates the similar
phenotypes resulting from disruption of
MDT-15, the SBP-1 transcription factor,
or of two of its targets, fat-6 and -7.
SREBP-mediated transcriptional acti-
vation of important target genes such
as the low density lipoprotein receptor
(LDLR), fatty acid synthase (FAS), and
3-hydroxy-3-methylglutaryl coenzyme A
(HMG CoA) synthase (in mammals) and
the Stearoyl CoA desaturases fat-6
and -7 (in worms) cannot occur without
the concomitant presence of ARC105.
These results demonstrate the crucial,
selective role of MDT-15 (and, by exten-
sion, ARC105) in regulating fatty acid
synthesis in animals. Without ARC105,
normal lipid homeostasis is disrupted
and the expected undesirable conse-
quences follow.
The complicated end-product feed-
back regulation of SREBP activation is
well known. Like SREBPs, ARC105 is
a crucial player in many aspects of the
transcriptional regulation of lipidmetabo-
lism. The selective interaction described
by Yang et al. (2006) raises questions.
From the point of view of cellular and or-
ganismal metabolism, themost intriguingquestion is: What, if anything, does
ARC105 contribute to metabolic regula-
tion of lipid metabolism? Why does tran-
scription by SREBP require a specific
component of the ARC/Mediator com-
plex rather than the components that
serve c-Myb and CREB?
It will be intriguing to learn if the activity
of ARC105 is regulated by metabolic
needs. Is the level of ARC105 present in
the nucleus coordinated with levels of
nuclear SREBPs and, if so, what mecha-
nisms might be employed to achieve
this? ARC105 does not appear to be
a target of SREBPs, for example (Horton
et al., 2003). Equally interesting will be
seeing whether ARC105 is required for
all SREBP-mediated transcription or for
only a subset of target promoters. Does
this putative subset require that different
ARC-component isoforms interact with
SREBPs? If so, what impact would this
have on lipid metabolism?
Yang et al. (2006) show that ARC105
interacts more strongly with SREBP-1a
than with either SREBP-1c or SREBP-2.
Future efforts may determine to what ex-
tent these differing affinities play a role in
transcriptional regulation. ARC105 does
not function in isolation, of course. It is
part of the ARC complex, many compo-
nents of which are found in modules
that vary depending on the transcription
factor with which the ARC complex inter-
acts (Naar et al., 2001). Do other ARC
subunits vary in concert with ARC105 or
is it alone in determining whether the
ARC complex interacts with SREBPs?
A final implication of the work consid-
ered here is that small molecules that al-
ter the interaction between SREBPs and
ARC105 might be novel therapeutic
agents for the treatment of various disor-
ders of lipid metabolism such as hyper-
lipidemias or metabolic syndrome.
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